135 related articles for article (PubMed ID: 23573978)
1. Intranasal vaccination.
Woodland DL
Viral Immunol; 2013 Apr; 26(2):125. PubMed ID: 23573978
[No Abstract] [Full Text] [Related]
2. Modern mucosal vaccines, adjuvants and microbicides.
Cranage MP; Manoussaka M
Expert Rev Anti Infect Ther; 2009 Feb; 7(1):21-3. PubMed ID: 19622054
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of local antibody production: parenteral or mucosal vaccination?
Bouvet JP; Decroix N; Pamonsinlapatham P
Trends Immunol; 2002 Apr; 23(4):209-13. PubMed ID: 11923116
[TBL] [Abstract][Full Text] [Related]
4. CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases.
Klinman DM; Klaschik S; Sato T; Tross D
Adv Drug Deliv Rev; 2009 Mar; 61(3):248-55. PubMed ID: 19272313
[TBL] [Abstract][Full Text] [Related]
5. [Mucosal viral vaccines: progress and problems].
Gendon IuZ
Vopr Virusol; 2003; 48(4):4-10. PubMed ID: 12945199
[TBL] [Abstract][Full Text] [Related]
6. [New routes of administration: epidermal, transcutaneous mucosal ways of vaccination].
Denis F; Alain S; Ploy MC
Med Sci (Paris); 2007 Apr; 23(4):379-85. PubMed ID: 17433227
[TBL] [Abstract][Full Text] [Related]
7. Optimization of vaccine responses in early life: the role of delivery systems and immunomodulators.
Kovarik J; Siegrist CA
Immunol Cell Biol; 1998 Jun; 76(3):222-36. PubMed ID: 9682966
[TBL] [Abstract][Full Text] [Related]
8. Mucosal vaccines: novel advances in technology and delivery.
Yuki Y; Kiyono H
Expert Rev Vaccines; 2009 Aug; 8(8):1083-97. PubMed ID: 19627189
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of new vaccines].
Eskola J; Kilpi T
Duodecim; 1996; 112(9):820-6. PubMed ID: 10592970
[No Abstract] [Full Text] [Related]
10. Letter from the editor.
Ellis RW; Riedmann EM
Hum Vaccin Immunother; 2014; 10(8):2137-8. PubMed ID: 25424915
[No Abstract] [Full Text] [Related]
11. Antibody-mediated protection and the mucosal immune system of the genital tract: relevance to vaccine design.
Mestecky J; Raska M; Novak J; Alexander RC; Moldoveanu Z
J Reprod Immunol; 2010 May; 85(1):81-5. PubMed ID: 20236708
[TBL] [Abstract][Full Text] [Related]
12. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
Brown TH; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock RE; Xing Z; Halperin SA; Wang J
Vaccine; 2012 Jan; 30(2):350-60. PubMed ID: 22075089
[TBL] [Abstract][Full Text] [Related]
13. [Intranasal vaccination of cattle against foot-and-mouth disease].
Bauer K; Straub OC
Berl Munch Tierarztl Wochenschr; 1985 Jul; 98(7):247-50. PubMed ID: 2994624
[No Abstract] [Full Text] [Related]
14. Intranasal administration of retinyl palmitate with a respiratory virus vaccine corrects impaired mucosal IgA response in the vitamin A-deficient host.
Surman SL; Jones BG; Rudraraju R; Sealy RE; Hurwitz JL
Clin Vaccine Immunol; 2014 Apr; 21(4):598-601. PubMed ID: 24554696
[TBL] [Abstract][Full Text] [Related]
15. Novel Th1-biased adjuvant, SPO1, enhances mucosal and systemic immunogenicity of vaccines administered intranasally in mice.
Yu S; Tang C; Shi X; Yang P; Xing L; Wang X
Vaccine; 2012 Aug; 30(36):5425-36. PubMed ID: 22709954
[TBL] [Abstract][Full Text] [Related]
16. Intranasal administration of CpG oligonucleotides induces mucosal and systemic Type 1 immune responses and adjuvant activity to porcine reproductive and respiratory syndrome killed virus vaccine in piglets in vivo.
Zhang L; Tian X; Zhou F
Int Immunopharmacol; 2007 Dec; 7(13):1732-40. PubMed ID: 17996683
[TBL] [Abstract][Full Text] [Related]
17. Fully mobilizing host defense: building better vaccines.
Raychaudhuri S; Rock KL
Nat Biotechnol; 1998 Nov; 16(11):1025-31. PubMed ID: 9831030
[TBL] [Abstract][Full Text] [Related]
18. Intranasal immunization with a non-adjuvanted adhesive protein descended from Pasteurella pneumotropica and its preventive efficacy against opportunistic infection in mice.
Sasaki H; Ishikawa H; Kojima K; Itoh M; Matsumoto T; Itoh T; Hosomi O; Kawamoto E
Vaccine; 2013 Nov; 31(48):5729-35. PubMed ID: 24091313
[TBL] [Abstract][Full Text] [Related]
19. Intranasal delivery of an adjuvanted modified live porcine reproductive and respiratory syndrome virus vaccine reduces ROS production.
Binjawadagi B; Dwivedi V; Manickam C; Torrelles JB; Renukaradhya GJ
Viral Immunol; 2011 Dec; 24(6):475-82. PubMed ID: 22111597
[TBL] [Abstract][Full Text] [Related]
20. Evidence based route of administration of vaccines.
Cook IF
Hum Vaccin; 2008; 4(1):67-73. PubMed ID: 17881890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
